MiR-181b Expression Levels as Molecular Biomarker for Type 2 Diabetes

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Aghaei Zarch Seyed Mohsen; Vahidi Mehrjardi Mohamad Yahya; Babakhanzadeh Emad; Nazari Majid; Talebi Mehrdad; Zeniali Fahime; DEHGHANI MOHAMMADREZA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download Full-Text

Persian Verion

View:

555

Download:

Cites:

Information Journal Paper

Title

MiR-181b Expression Levels as Molecular Biomarker for Type 2 Diabetes

Author(s)

Keywords

type 2 diabetesQ2

miR-181bQ1

biomarkerQ1

Abstract

Background and purpose: type 2 diabetes mellitus (T2DM) as a progressive metabolic disorder is rising very fast around the world. Diagnosis of T2DM at early stages (prediabetic) is important in reducing the mortality associated with this disease. Several studies have shown that micro-RNAs play a major role in the pathogenesis of the T2DM. Because of the high stability of these regulatory RNA in body fluids and the availability of sensitive technology, such as Real-time PCR for detecting them, they can be used as epigenetic biomarker in the early diagnosis of T2DM. In this study, for the first time, miR-181 expression levels were investigated in patients with T2DM in Yazd province, Iran. Materials and methods: In this experimental study, Real-time PCR was used to quantify expression levels of miR-181b in 90 individuals including T2DM patients (n=30), prediabetic (n=30), and healthy individuals (n=30). Results: There were significant differences in miR-181b expression levels between the groups studied. Conclusion: Reduced miR-181b expression levels in T2DM and pre-diabetic subjects compared to healthy individuals suggests that miR-181b could be used as a new epigenetic diagnostic marker for early diagnosis of T2DM.

Cites

No record.

References

No record.

Cite

APA: Copy

Aghaei Zarch, Seyed Mohsen, Vahidi Mehrjardi, Mohamad Yahya, Babakhanzadeh, Emad, Nazari, Majid, Talebi, Mehrdad, Zeniali, Fahime, & DEHGHANI, MOHAMMADREZA. (2019). MiR-181b Expression Levels as Molecular Biomarker for Type 2 Diabetes. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, 29(176), 195-201. SID. https://sid.ir/paper/363243/en

Vancouver: Copy

Aghaei Zarch Seyed Mohsen, Vahidi Mehrjardi Mohamad Yahya, Babakhanzadeh Emad, Nazari Majid, Talebi Mehrdad, Zeniali Fahime, DEHGHANI MOHAMMADREZA. MiR-181b Expression Levels as Molecular Biomarker for Type 2 Diabetes. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2019;29(176):195-201. Available from: https://sid.ir/paper/363243/en

IEEE: Copy

Seyed Mohsen Aghaei Zarch, Mohamad Yahya Vahidi Mehrjardi, Emad Babakhanzadeh, Majid Nazari, Mehrdad Talebi, Fahime Zeniali, and MOHAMMADREZA DEHGHANI, “MiR-181b Expression Levels as Molecular Biomarker for Type 2 Diabetes,” JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, vol. 29, no. 176, pp. 195–201, 2019, [Online]. Available: https://sid.ir/paper/363243/en

Related Journal Papers